Citi has maintained a 'buy' rating on RBL Bank shares and raised its target price to Rs 285, projecting a 19% upside over the next 90 days. The brokerage expects an improvement in the bank's return on assets (RoA) to 45-50 basis points, with slippages moderating to approximately 4.5% compared to 4.7% in the previous quarter. Citi also anticipates that net interest margins (NIMs) will bottom out sooner in the first quarter compared to peers. Following Citi's positive catalyst watch, RBL Bank shares rose nearly 4%. In related market movements, Mahindra & Mahindra Financial Services shares increased by 2% after releasing their Q1 business update, while Motilal Oswal Financial shares gained 6% after its asset under management (AUM) crossed Rs 1.5 trillion. Other notable stock performances include CSB Bank rising 3% on a healthy Q1 business report, Coromandel International shares showing strong activity, and Arkade Developers shares climbing 4.5% following its acquisition of Filmistan and announcement of a Rs 3,000 crore gross development value (GDV) project in Mumbai. Hospital stocks such as Max, Aster DM, and Apollo rallied up to 7%, contributing to a broader positive trend in capital market stocks with Motilal Oswal, BSE, and Angel One rising up to 6% as the Nifty index approached an all-time high.